|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
|
|---|---|---|---|---|---|
| Sales and other revenues | |||||
| Operating costs and expenses: | |||||
| Cost of products sold (exclusive of lower of cost or market inventory valuation adjustment) | |||||
| Lower of cost or market inventory valuation adjustment | |||||
| Cost of products sold (exclusive of depreciation and amortization) | |||||
| Operating expenses (exclusive of depreciation and amortization) | |||||
| Selling, general and administrative expenses (exclusive of depreciation and amortization) | |||||
| Depreciation and amortization | |||||
| Goodwill and long-lived asset impairments | |||||
| Total operating costs and expenses | |||||
| Income (loss) from operations | |||||
| Other income (expense): | |||||
| Earnings of equity method investments | |||||
| Interest income | |||||
| Interest expense | |||||
| Gain on business interruption insurance settlement | |||||
| Gain on tariff settlement | |||||
| Gain on sales-type leases | |||||
| Loss on early extinguishment of debt | |||||
| Gain on foreign currency transactions | |||||
| Gain (loss) on foreign currency transactions | |||||
| Remeasurement gain on HEP pipeline interest acquisitions | |||||
| Gain on sale of assets and other | |||||
| Other income (expense) total | |||||
| Income (loss) before income taxes | |||||
| Income tax expense (benefit): | |||||
| Current | |||||
| Deferred | |||||
| Income tax expense (benefit) total | |||||
| Net income (loss) | |||||
| Less net income attributable to noncontrolling interest | |||||
| Net income (loss) attributable to HollyFrontier stockholders | |||||
| Earnings (loss) per share: | |||||
| Basic (in USD per share) | |||||
| Diluted (in USD per share) | |||||
| Average number of common shares outstanding: | |||||
| Average number of shares of common stock outstanding - basic (in shares) | |||||
| Average number of shares of common stock outstanding - diluted (in shares) |
Loading...